Forensic Fluids Laboratories Launches SARS-CoV-2 Antibodies Serological Testing

Forensic Fluids Laboratories (FFL) today announced it has begun testing for SARS-CoV-2 antibodies via serum to further understand a person’s history of COVID-19 exposure. 

FFL, a CLIA certified drug testing laboratory located in Kalamazoo, Michigan, is now able to test serum samples for the Immunoglobulin G (IgG) and Immunoglobulin M (IgM) antibody; and also has a Total Antibody test that is FDA approved. The test results allow those who are symptomatic and asymptomatic to make better informed decisions for continuing on with their lifestyle activities. Furthermore, FFL has the capacity to run a high number of tests, at a rate of 1,500-4,000 per 8 hour shift.

“With proven results in our pilot testing, we want to expand our testing to additional first responders and medical personnel who are on the frontlines of the COVID-19 pandemic, including hospital and ambulance personnel, EMTs, fire/rescue, public safety and police officers,” said Bridget Lorenz Lemberg, Toxicologist and Laboratory Director of Forensic Fluids Laboratories. “This is one small way we, at Forensic Fluids Laboratories, can help fight this virus and help our everyday heroes.”

In order for FFL to conduct the SARS-CoV-2 antibodies test, a person must obtain a blood sample drawn by a phlebotomist and FFL will test the serum sample for SARS-CoV-2 antibodies. Test results showing an IgG positive may suggest there was an immune response to the virus.

 “This is a scientifically accurate and sensitive way to see if our first responders and emergency medical workers have been exposed to the COVID-19 virus,” said Lorenz Lemberg.

FFL continues to work with all hospital and first responder employees in Michigan to conduct antibodies testing through its lab.